Ikarian Capital, LLC Portfolio Holdings

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Ikarian Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $573 Million distributed in 145 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tarsus Pharmaceuticals, Inc. with a value of $33.9M, Crinetics Pharmaceuticals, Inc. with a value of $21.8M, Bei Gene, Ltd. with a value of $19.8M, Viridian Therapeutics, Inc.\De with a value of $11.4M, and Arcus Biosciences, Inc. with a value of $11.4M.

Examining the 13F form we can see an increase of $325M in the current position value, from $247M to 573M.

Ikarian Capital, LLC is based out at Dallas, TX

Below you can find more details about Ikarian Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $573 Million
Healthcare: $523 Million
ETFs: $49.4 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.41B
$33.9 Million 5.92% of portfolio
1,030,277
Q3 2024 Added 28.74%
$2.9B
$21.8 Million 3.81% of portfolio
426,913
Q3 2024 Reduced 27.5%
$18.3B
$19.8 Million 3.46% of portfolio
88,167
Q3 2024 New
$759M
$11.4 Million 1.99% of portfolio
499,977
Q3 2024 New
$1.12B
$11.4 Million 1.99% of portfolio
744,000
Q3 2024 Added 413.1%
$9.54B
$11.3 Million 1.97% of portfolio
154,835
Q3 2024 Added 223.69%
$247M
$10.7 Million 1.87% of portfolio
587,343
Q3 2024 Added 15.92%
$3.1B
$9.94 Million 1.74% of portfolio
179,000
Q3 2024 New
$4.6B
$8.98 Million 1.57% of portfolio
170,147
Q2 2024 Added 17.22%
$2.19B
$8.31 Million 1.45% of portfolio
417,850
Q3 2024 Reduced 19.39%
$5.38B
$7.86 Million 1.37% of portfolio
85,000
Q3 2024 New
$3.93B
$7.27 Million 1.27% of portfolio
285,613
Q3 2024 Reduced 13.98%
$10.4B
$6.77 Million 1.18% of portfolio
54,176
Q3 2024 Reduced 73.39%
$935M
$5.84 Million 1.02% of portfolio
260,000
Q3 2024 Reduced 40.98%
$3.62B
$5.34 Million 0.93% of portfolio
52,238
Q3 2024 Reduced 65.54%
$522M
$4.91 Million 0.86% of portfolio
693,350
Q3 2024 New
$1.17B
$4.46 Million 0.78% of portfolio
544,265
Q3 2024 Reduced 5.36%
$166M
$4.3 Million 0.75% of portfolio
887,230
Q3 2024 Reduced 1.83%
$141B
$4.29 Million 0.75% of portfolio
13,300
Q3 2024 Reduced 65.27%
$2.41B
$4.22 Million 0.74% of portfolio
107,187
Q1 2024 New
$611M
$4.18 Million 0.73% of portfolio
258,279
Q3 2024 New
$875M
$3.64 Million 0.64% of portfolio
197,096
Q2 2024 Reduced 33.66%
$33.9M
$3.69 Million 0.64% of portfolio
583,593
Q3 2024 Reduced 24.07%
$59.3M
$3.51 Million 0.61% of portfolio
957,408
Q3 2024 Reduced 42.41%
$220M
$2.57 Million 0.45% of portfolio
308,497
Q3 2024 Reduced 32.72%
$30.2B
$2.4 Million 0.42% of portfolio
8,741
Q3 2024 New
$41.1M
$1.74 Million 0.3% of portfolio
1,025,668
Q3 2024 New
$363M
$1.73 Million 0.3% of portfolio
202,908
Q3 2024 Reduced 33.01%
$174M
$1.71 Million 0.3% of portfolio
1,312,405
Q2 2024 New
$324M
$1.65 Million 0.29% of portfolio
311,593
Q3 2024 New
$40M
$1.47 Million 0.26% of portfolio
1,443,181
Q1 2024 New
$450M
$1.24 Million 0.22% of portfolio
476,586
Q1 2024 Added 15.43%
$8.15B
$1.16 Million 0.2% of portfolio
100,609
Q1 2024 Reduced 33.73%
$99M
$1.08 Million 0.19% of portfolio
704,987
Q1 2024 Added 2.38%
$247M
$1.1 Million 0.19% of portfolio
92,000
Q3 2024 New
$94.7M
$906,000 0.16% of portfolio
100,370
Q2 2024 New
$237M
$889,000 0.16% of portfolio
274,551
Q2 2024 Reduced 17.17%
$109M
$891,000 0.16% of portfolio
175,100
Q3 2024 Added 75.1%
$188M
$880,000 0.15% of portfolio
483,583
Q1 2024 Added 2.32%
$436M
$823,000 0.14% of portfolio
1,068,992
Q3 2024 Added 23.02%
$264M
$802,000 0.14% of portfolio
78,574
Q2 2024 Reduced 22.45%
$30.6M
$814,000 0.14% of portfolio
493,496
Q2 2024 Reduced 69.39%
$344M
$822,000 0.14% of portfolio
170,000
Q3 2024 New
$61.9M
$769,000 0.13% of portfolio
367,965
Q1 2024 New
$52.1M
$728,000 0.13% of portfolio
946,382
Q1 2024 New
$151M
$725,000 0.13% of portfolio
526,066
Q2 2024 New
$74.9M
$660,000 0.12% of portfolio
266,435
Q1 2024 Reduced 15.49%
$54M
$708,000 0.12% of portfolio
466,019
Q1 2024 Added 0.69%
$102M
$632,000 0.11% of portfolio
972,675
Q2 2024 Added 4.29%

Summary

  • Portfolio
  • No. of Stocks 145
  • Current Value $573 Million
  • Prior Value $247 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 21 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 28 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email